Acute Imidacloprid Poisoning in Thailand

Charuwan Sriapha,1 Satariya Trakulsrichai,1,2 Achara Tongpoo,1 Aimon Pradoo,1 Panee Rittilert,1 Winai Wananukul1,3 1Ramathibodi Poison Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand; 2Department of Emergency Medicine, Faculty of Medicine Ramathibodi Hos...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sriapha C, Trakulsrichai S, Tongpoo A, Pradoo A, Rittilert P, Wananukul W
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/52487ff975e541a59d3067662aacd6e8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:52487ff975e541a59d3067662aacd6e8
record_format dspace
spelling oai:doaj.org-article:52487ff975e541a59d3067662aacd6e82021-12-02T12:46:32ZAcute Imidacloprid Poisoning in Thailand1178-203Xhttps://doaj.org/article/52487ff975e541a59d3067662aacd6e82020-11-01T00:00:00Zhttps://www.dovepress.com/acute-imidacloprid-poisoning-in-thailand-peer-reviewed-article-TCRMhttps://doaj.org/toc/1178-203XCharuwan Sriapha,1 Satariya Trakulsrichai,1,2 Achara Tongpoo,1 Aimon Pradoo,1 Panee Rittilert,1 Winai Wananukul1,3 1Ramathibodi Poison Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand; 2Department of Emergency Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 1400, Thailand; 3Division of Clinical Pharmacology and Toxicology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 1400, ThailandCorrespondence: Satariya TrakulsrichaiRamathibodi Poison Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, ThailandTel +66-2-2011084Fax +66-2-2011086Email satariya.tra@mahidol.ac.thIntroduction: Imidacloprid is the most commonly used neonicotinoid insecticide worldwide. Despite its reputation for safety, there is increasing evidence regarding its toxicity. This study characterized the clinical manifestations and outcomes of acute imidacloprid poisoning.Methods: This was a retrospective study of patients with imidacloprid poisoning who were referred to the Ramathibodi Poison Center in Bangkok, Thailand between 2010 and 2018.Results: A total of 163 patients with imidacloprid-only exposure were included. Most were exposed by ingestion (93.3%). The patients were predominantly male (55.8%), with a median age of 41.3 years. The common presenting features were gastrointestinal symptoms (63.8%) with no corrosive injuries and neurological effects (14.2%). The majority of medical outcomes was no (18.4%) to mild (76.1%) toxicity. One patient had symptoms mimicking cholinergic syndrome, three developed liver injury, and five died. Among the five deaths, two patients presented severe initial severity, and one presented moderate initial severity. Two of the patients who died initially presented only mild severity. The mortality rate was 3.1%. The estimated amount of ingestion, cardiovascular effects (especially tachycardia and cardiac arrest), central nervous system effects (especially coma), dyspnea, and diaphoresis were significantly associated with mortality. Patient management primarily included supportive and symptomatic care.Conclusion: Most patients with imidacloprid poisoning developed only mild toxicity. The mortality rate was low, but a few patients with mild initial severity died. Patients who ingest a large amount or show these warning signs including cardiovascular effects, central nervous system effects, dyspnea, and diaphoresis at the initial presentation should be considered for close observation and monitoring.Keywords: imidacloprid, neonicotinoid insecticide, poisoning, toxicity, humansSriapha CTrakulsrichai STongpoo APradoo ARittilert PWananukul WDove Medical Pressarticleimidaclopridneonicotinoid insecticidepoisoningtoxicityhumansTherapeutics. PharmacologyRM1-950ENTherapeutics and Clinical Risk Management, Vol Volume 16, Pp 1081-1088 (2020)
institution DOAJ
collection DOAJ
language EN
topic imidacloprid
neonicotinoid insecticide
poisoning
toxicity
humans
Therapeutics. Pharmacology
RM1-950
spellingShingle imidacloprid
neonicotinoid insecticide
poisoning
toxicity
humans
Therapeutics. Pharmacology
RM1-950
Sriapha C
Trakulsrichai S
Tongpoo A
Pradoo A
Rittilert P
Wananukul W
Acute Imidacloprid Poisoning in Thailand
description Charuwan Sriapha,1 Satariya Trakulsrichai,1,2 Achara Tongpoo,1 Aimon Pradoo,1 Panee Rittilert,1 Winai Wananukul1,3 1Ramathibodi Poison Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand; 2Department of Emergency Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 1400, Thailand; 3Division of Clinical Pharmacology and Toxicology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 1400, ThailandCorrespondence: Satariya TrakulsrichaiRamathibodi Poison Center, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok 10400, ThailandTel +66-2-2011084Fax +66-2-2011086Email satariya.tra@mahidol.ac.thIntroduction: Imidacloprid is the most commonly used neonicotinoid insecticide worldwide. Despite its reputation for safety, there is increasing evidence regarding its toxicity. This study characterized the clinical manifestations and outcomes of acute imidacloprid poisoning.Methods: This was a retrospective study of patients with imidacloprid poisoning who were referred to the Ramathibodi Poison Center in Bangkok, Thailand between 2010 and 2018.Results: A total of 163 patients with imidacloprid-only exposure were included. Most were exposed by ingestion (93.3%). The patients were predominantly male (55.8%), with a median age of 41.3 years. The common presenting features were gastrointestinal symptoms (63.8%) with no corrosive injuries and neurological effects (14.2%). The majority of medical outcomes was no (18.4%) to mild (76.1%) toxicity. One patient had symptoms mimicking cholinergic syndrome, three developed liver injury, and five died. Among the five deaths, two patients presented severe initial severity, and one presented moderate initial severity. Two of the patients who died initially presented only mild severity. The mortality rate was 3.1%. The estimated amount of ingestion, cardiovascular effects (especially tachycardia and cardiac arrest), central nervous system effects (especially coma), dyspnea, and diaphoresis were significantly associated with mortality. Patient management primarily included supportive and symptomatic care.Conclusion: Most patients with imidacloprid poisoning developed only mild toxicity. The mortality rate was low, but a few patients with mild initial severity died. Patients who ingest a large amount or show these warning signs including cardiovascular effects, central nervous system effects, dyspnea, and diaphoresis at the initial presentation should be considered for close observation and monitoring.Keywords: imidacloprid, neonicotinoid insecticide, poisoning, toxicity, humans
format article
author Sriapha C
Trakulsrichai S
Tongpoo A
Pradoo A
Rittilert P
Wananukul W
author_facet Sriapha C
Trakulsrichai S
Tongpoo A
Pradoo A
Rittilert P
Wananukul W
author_sort Sriapha C
title Acute Imidacloprid Poisoning in Thailand
title_short Acute Imidacloprid Poisoning in Thailand
title_full Acute Imidacloprid Poisoning in Thailand
title_fullStr Acute Imidacloprid Poisoning in Thailand
title_full_unstemmed Acute Imidacloprid Poisoning in Thailand
title_sort acute imidacloprid poisoning in thailand
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/52487ff975e541a59d3067662aacd6e8
work_keys_str_mv AT sriaphac acuteimidaclopridpoisoninginthailand
AT trakulsrichais acuteimidaclopridpoisoninginthailand
AT tongpooa acuteimidaclopridpoisoninginthailand
AT pradooa acuteimidaclopridpoisoninginthailand
AT rittilertp acuteimidaclopridpoisoninginthailand
AT wananukulw acuteimidaclopridpoisoninginthailand
_version_ 1718393685568126976